Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Disease 2Colonic Polyps 2Turcot syndrome 1Recurrence 1Pathologic Complete Response 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Colon Cancer Screening 1

Interventions

Cyclophosphamide 6fludarabine 5toripalimab 3Paclitaxel 3Etoposide 3Carboplatin 3Bevacizumab 3zimberelimab 2tislelizumab 2sintilimab 2glumetinib 2Vincristine 2Temozolomide 2Platinum 2Immune Checkpoint Inhibitors 2Hepatectomy 2Gemcitabine 2Drug Therapy 2Docetaxel 2Cisplatin 2Capecitabine 2venetoclax 1relmacabtagene autoleucel 1osimertinib 1lenvatinib 1irinotecan sucrosofate 1glofitamab 1gallium maltolate 1fludarabine phosphate 1eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Recurrence × Colonoscopy × Clear all
NCT06791616 2025-01-24

Surveillance Intervals After Piecemeal Resection of Non-pedunculated Colorectal Lesions ≥20mm

Asociación Española de Gastroenterología

Phase NA Not yet recruiting
746 enrolled
Gastrointestinal

Colonic Polyps, Recurrence, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡